Senescence-associated reprogramming promotes cancer stemness
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Cellular senescence is a stress-responsive cell-cycle arrest program that terminates the further expansion of (pre-)malignant cells. Key signalling components of the senescence machinery, such as p16 INK4a, p21 CIP1 and p53, as well as trimethylation of lysine 9 at histone H3 (H3K9me3), also operate as critical regulators of stem-cell functions (which are collectively termed 'stemness'). In cancer cells, a gain of stemness may have profound implications for tumour aggressiveness and clinical outcome. Here we investigated whether chemotherapy-induced senescence could change stem-cell-related properties of malignant cells. Gene expression and functional analyses comparing senescent and non-senescent B-cell lymphomas from Eμ-Myc transgenic mice revealed substantial upregulation of an adult tissue stem-cell signature, activated Wnt signalling, and distinct stem-cell markers in senescence. Using genetically switchable models of senescence targeting H3K9me3 or p53 to mimic spontaneous escape from the arrested condition, we found that cells released from senescence re-entered the cell cycle with strongly enhanced and Wnt-dependent clonogenic growth potential compared to virtually identical populations that had been equally exposed to chemotherapy but had never been senescent. In vivo, these previously senescent cells presented with a much higher tumour initiation potential. Notably, the temporary enforcement of senescence in p53-regulatable models of acute lymphoblastic leukaemia and acute myeloid leukaemia was found to reprogram non-stem bulk leukaemia cells into self-renewing, leukaemia-initiating stem cells. Our data, which are further supported by consistent results in human cancer cell lines and primary samples of human haematological malignancies, reveal that senescence-associated stemness is an unexpected, cell-autonomous feature that exerts its detrimental, highly aggressive growth potential upon escape from cell-cycle blockade, and is enriched in relapse tumours. These findings have profound implications for cancer therapy, and provide new mechanistic insights into the plasticity of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persistent senescent cells are known to exert detrimental long-term effects on organ function and can promote tumorigenesis33,96,112,177,178.”
From COVID-19 and cellular senescence (2023) · cites this paper as [177]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the senescence programme is associated with enhanced stemness through cell- autonomous and cell- non- autonomous mechanisms”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Continuous transcriptional or, more generally, functional changes in senescent cells, and the permanent need to actively maintain senescencesupporting transcription puts the stability of cell cycle arrest at risk, occasionally leading to the restoration of proliferative properties with a potentially detrimental effect on tumour suppression 5,79 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conversely, inactivation of Tp53 , the genes encoding either one of the three Rb family members or Suv39h1 in already senescent cells enables cell cycle re- entry out of the terminal arrest condition 5,125,126 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, retained senescence- associated gain of stemness in senescence escapers has been demonstrated in samples derived from patients with relapsed diffuse large B cell lymphoma that exhibited strong enrichment for WNT signalling activity reminiscent of senescence- associated stemness 5 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measured
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Rappsilber, J., Mann, M., & Ishihama, Y. (2007) · Nature Protocols · doi:10.1038/nprot.2007.261 · Cited by 4,641
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Cited by
Items 701–800 of 1,000
Kang, D., Lim, Y., Ahn, D., Lee, J., & Park, C. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00537 · Cited by 9
Denker, S., Bittner, A., Na, I., Kase, J., Frick, M., Anagnostopoulos, I., Hummel, M., & Schmitt, C. A. (2019) · International Journal of Hematologic Oncology · doi:10.2217/ijh-2019-0010 · Cited by 8
Self-citationMorris, C., Durand, S., & Jalinot, P. (2021) · Oncotarget · doi:10.18632/oncotarget.27923 · Cited by 8
Lima, I. B., Alvarenga, B. M., de Tótaro, P. I. S., Boratto, F., Leite, E. A., & Guimarães, P. P. G. (2023) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2023220572 · Cited by 8
Self-Renewal Inhibition in Breast Cancer Stem Cells: Moonlight Role of PEDF in Breast Cancer
Gil‐Gas, C., Sánchez‐Díez, M., Honrubia‐Gómez, P., Sánchez-Sánchez, J., Álvarez‐Simón, C. B., Sabater, S., Sánchez‐Sánchez, F., & Ramírez‐Castillejo, C. (2023) · Cancers · doi:10.3390/cancers15225422 · Cited by 8
Wilczyński, J. R., Paradowska, E., Wilczyńska, J., & Wilczyński, M. (2023) · Current Oncology · doi:10.3390/curroncol31010015 · Cited by 9
Cellular senescence, geroscience, cancer and beyond
Rodier, F., Zhou, D., & Ferbeyre, G. (2018) · Aging · doi:10.18632/aging.101546 · Cited by 8
Femtosecond-laser stimulation induces senescence of tumor cells in vitro and in vivo
Zhao, X., Tang, W., Wang, H., & He, H. (2021) · Biomedical Optics Express · doi:10.1364/boe.449456 · Cited by 9
Mehdizadehtapeh, L., & Yerlikaya, P. O. (2021) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2010-62 · Cited by 8
Wu, H., Liu, G., Zhang, Z.-Y., Wu, W., Meng, Y., Wang, S., Yang, W., & Yan, K. (2021) · International Journal of Hyperthermia · doi:10.1080/02656736.2021.1912415 · Cited by 8
Cellular senescence limits translational readthrough
Toro, N. D., Lessard, F., Bouchard, J., Mobasheri, N., Guillon, J., Igelmann, S., Tardif, S., Buffard, T., Bourdeau, V., Brakier‐Gingras, L., et al. (2021) · Biology Open · doi:10.1242/bio.058688 · Cited by 8
Murillo, L. L., Sugden, C. J., Ózsvári, B., Moftakhar, Z., Hassan, G. S., Sotgia, F., & Lisanti, M. P. (2024) · Cells · doi:10.3390/cells13242059 · Cited by 7
Takenouchi, S., Ito, Y., Nakamura, K., Nakagawa-Saito, Y., Mitobe, Y., Togashi, K., Suzuki, S., Sugai, A., Sonoda, Y., Kitanaka, C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146984 · Cited by 7
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer
Cerra, C., Tancock, M. R. C., Thio, N., Koo, A., Wong, A., Cowley, K. J., Varshney, S., Willis, M. O., Simpson, K. J., Australian Ovarian Cancer Study Group, et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02716-1 · Cited by 7
Jiang, C., Tuo, Z., Wusiman, D., Wang, J., Yao, H., Cho, W. C., Lyu, Z., Zhang, Q., & Feng, D. (2026) · International Journal of Biological Sciences · doi:10.7150/ijbs.130683 · Cited by 8
Cellular senescence and senescence-associated secretory phenotype (SASP) in aging process
Olivieri, F., Procopio, A. D., & Rippo, M. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822569-1.00013-5 · Cited by 11
Kim, Y., Lee, J.-H., Lee, C., & Lawler, S. E. (2022) · Journal of Mathematical Biology · doi:10.1007/s00285-022-01850-z · Cited by 7
Lin, S., Ma, L., Mo, J., Zhao, R., Li, J., Yu, M., Jiang, M., & Peng, L. (2024) · Aging · doi:10.18632/aging.205778 · Cited by 10
Zhang, Y., Chu, J., Hou, Q., Qian, S., Wang, Z., Yang, Q., Song, W., Dong, L., Shi, Z., Gao, Y., et al. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5653 · Cited by 7
PQBP3 prevents senescence by suppressing PSME3-mediated proteasomal Lamin B1 degradation
Yoshioka, Y., Huang, Y., Jin, X., Ngo, K. X., Kumaki, T., Jin, M., Toyoda, S., Takayama, S., Inotsume, M., Fujita, K., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00192-4 · Cited by 8
Naffaa, M. M., & Al-Ewaidat, O. A. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001314 · Cited by 7
In vitro senescence and senolytic functional assays
Ryan, P., & Lee, J. (2025) · Biomaterials Science · doi:10.1039/d4bm01684j · Cited by 7
Zhang, Y., Qian, S., Wen, Q., Lei, Y., Ge, J., Kong, X., Wang, W., Wang, Z., Hou, H., Tang, C., et al. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03128-2 · Cited by 8
Xing, T., Hu, Y., Wang, H., & Zou, Q. (2023) · Medicine · doi:10.1097/md.0000000000033739 · Cited by 7
Kuang, M., Chen, Y., Xing, Y., Du, M., Feng, H., Yang, Q., Wen, D., Li, X., Yang, K., Lin, Z., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02501-7 · Cited by 7
Feng, D., Wang, J., Li, D., Wu, R., Wei, W., & Zhang, C. (2023) · Discover Oncology · doi:10.1007/s12672-023-00777-1 · Cited by 7
Song, Y., Zhao, X., Qu, H., Su, Y., He, R., Chen, L., Fang, L., Li, J., Zou, Z., He, J., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300023 · Cited by 7
Cellular senescence: A potential mode of circular RNAs regulating prostate cancer
Li, Y., Fan, A., Zhang, Y., Guo, Z., Meng, W., Pan, W., Ma, Z., & Chen, W. (2023) · MedComm – Oncology · doi:10.1002/mog2.61 · Cited by 9
Celeste, F., & Powers, S. (2024) · Cancers · doi:10.3390/cancers16051001 · Cited by 7
Wang, F., Zhang, S., Sun, F., Chen, W., Liu, C., Dong, H., Cui, B., Li, L., Sun, C., Du, W., et al. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00799-z · Cited by 7
Self-citationTrzaskoma, P., Jung, S., Kanno, Y., O’Shea, J. J., & Chow, C. C. (2024) · Neoplasia · doi:10.1016/j.neo.2024.101071 · Cited by 8
Targeting the stress support network regulated by autophagy and senescence for cancer treatment
Kim, J., Lee, Y., Roh, K., Kim, M.-S., & Kang, C. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.003 · Cited by 7
Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy
Lee-Theilen, M., Fadini, D. D., Hadhoud, J. R., van Dongen, F., Kroll, G., Rolle, U., & Fiegel, H. C. (2022) · Cancers · doi:10.3390/cancers14235825 · Cited by 7
Agrawal, K., Das, V., Kudlová, N., Gurský, J., Džubák, P., & Hajdúch, M. (2018) · Stem Cells International · doi:10.1155/2018/6013728 · Cited by 7
Dormancy: There and Back Again
Пшенникова, Е. С., & Voronina, A. S. (2022) · Molecular Biology · doi:10.1134/s0026893322050119 · Cited by 9
Overview of molecular signatures of senescence and associated resources: pros and cons
Ntintas, O. A., Vagena, S., Pantelis, P., Theocharous, G., Petty, R., Evangelou, K., & Gorgoulis, V. G. (2026) · FEBS Open Bio · doi:10.1002/2211-5463.70134 · Cited by 6
“However, in advanced stages, it can promote malignancies, either through the SASP or, more importantly, via the “escape from senescence” phenomenon [18,39 – 41].”
Bugia, L., Affolter, A., Kern, J., Sohn, E., Jungbauer, F., Fleckenstein, J., Lammert, A., Rotter, N., & Scherl, C. (2025) · Oncology Reports · doi:10.3892/or.2025.8984 · Cited by 6
Shahzaib, M., Aprile, D., Squillaro, T., Alessio, N., Peluso, G., Bernardo, G. D., & Galderisi, U. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102916 · Cited by 7
Menéndez, J. A., Lupu, R., Martín-Castillo, B., Sardanyés, J., Alarcón, T., Verdura, S., & Cuyàs, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1695244 · Cited by 7
Cellular senescence and nanoparticle-based therapies: Current developments and perspectives
Henschke, A., Mielcarek, A., Grześkowiak, B. F., Perrigue, P. M., Jaskot, K., Coy, E. L., & Moya, S. E. (2024) · Nanotechnology Reviews · doi:10.1515/ntrev-2023-0211 · Cited by 6
He, Y., Long, K., Du, B., Liao, W., Zou, R., Su, J., Luo, J., Shi, Z., & Wang, L. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150576 · Cited by 7
Zhou, Y., Yang, K., Zhang, Z., Wei, F., Chen, L., Luo, D., Yang, Z., Zhao, K., Xie, N., Li, W., et al. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00732.2023 · Cited by 6
NCBP2 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis
Li, S., Wang, Y., Yang, X., Li, M., Li, G., Song, Q., & Liu, J. (2025) · PeerJ · doi:10.7717/peerj.19050 · Cited by 6
Llerena, J. L. G., Treviño-Almaguer, D., Leal-Mendez, J. A., Garcia-Valdez, G., Balderas-Moreno, A. G., Heya, M. S., Balderas-Rentería, I., Camacho‐Corona, M. D. R., & Espinosa-Rodríguez, B. A. (2025) · Pharmaceuticals · doi:10.3390/ph18050667 · Cited by 6
Evolutionary conservation and cancer implications of the WNT signaling pathway
Prajapati, D., Ambere, G. D., Mathure, D. M., Karati, D., & Kumar, D. (2025) · Medical Oncology · doi:10.1007/s12032-025-02950-8 · Cited by 6
Functional screening to identify senescence regulators in cancer
Lujambio, A., & Banito, A. (2019) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2019.02.001 · Cited by 6
Molecular basis of sex differences in cancer: Perspective from Asia
Ornos, E. D. B., Cando, L. F. T., Catral, C. D. M., Quebral, E. P. B., Tantengco, O. A. G., Arevalo, M. V. P. N., & Dee, E. C. (2023) · iScience · doi:10.1016/j.isci.2023.107101 · Cited by 6
Hu, Z., Zhang, M., Fan, J., Hu, J., Lin, G., Piao, S., Liu, P., Liu, J., Fu, S., Sun, W., et al. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00403 · Cited by 6
Shen, H., Chen, Y., Xu, M., Zhou, J., Huang, C., Wang, Z., Shao, Y., Zhang, H., Lu, Y., Li, S., et al. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03702-9 · Cited by 6
Chemo-Senolytic Therapeutic Potential against Angiosarcoma
Wang, X., Chung, C., Yoshioka, A., Hashimoto, S., Jimbo, H., Tanizawa, H., Ohta, S., Fukumoto, T., & Noma, K.-I. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.03.026 · Cited by 7
SATB1, senescence and senescence‐related diseases
Qi, W., Bai, J., Wang, R., Zeng, X., & Zhang, L. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31327 · Cited by 6
VpreB surrogate light chain expression in B-lineage ALL: a report from the Children’s Oncology Group
Winter, S. S., McCaustland, A., Qu, C., Simeona, N., Heerema, N. A., Carroll, A. J., Wood, B. L., Gheorghe, G. S., Mullighan, C. G., & Wilson, B. S. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005245 · Cited by 6
Zhao, H., Lin, L. F., Hahn, J., Xie, J., Holman, H. F., & Yuan, C. (2022) · Life · doi:10.3390/life12030438 · Cited by 7
Liu, H., Wang, H., Ni, D., & Xu, Y. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01694-1 · Cited by 6
BTG2 acts as an inducer of muscle stem cell senescence
Peng, B., Chen, Y., Wang, Y., Fu, Y., Zeng, X., Zhou, H., Abulaiti, Z., Wang, S., & Zhang, H. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.05.098 · Cited by 6
Akagi, K., Koizumi, K., Kadowaki, M., Kitajima, I., & Saito, S. (2023) · Cells · doi:10.3390/cells12182297 · Cited by 8
Guo, B., Rodriguez‐Gabin, A., Prota, A. E., Mühlethaler, T., Zhang, N., Ye, K. Q., Steinmetz, M. O., Horwitz, S. B., Smith, A. B., & McDaid, H. M. (2020) · Molecular Pharmacology · doi:10.1124/mol.119.117457 · Cited by 6
AP-1 Imprints a Reversible Transcriptional Program of Senescent CellsPreprint
Martínez-Zamudio, R. I., Roux, P., de Freitas, J. A. N. L. F., Robinson, L. J., Doré, G. R. G., Sun, B., Gil, J., Herbig, U., & Bischof, O. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/633594 · Cited by 6
Landragin, C., Saichi, M., Prompsy, P., Durand, A., Mesple, J., Trouchet, A., Faraldo, M. M., Salmon, H., & Vallot, C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.08.494710 · Cited by 6
SOX2 drives fetal reprogramming and reversible dormancy in colorectal cancerPreprint
Baulies, A., Moncho-Amor, V., Garcia, D. D., Kucharska, A., Chakravarty, P., Moreno‐Valladares, M., Cruces‐Salguero, S., Hubl, F., Hutton, C., Kim, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.11.612412 · Cited by 7
Senescence as a therapeutic target
Meyer, K. R., Lopez-Dominguez, J. A., Maus, M., Kovatcheva, M., & Serrano, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00014-6 · Cited by 6
Cazzaniga, C., Göder, A., Rainey, M. D., Quinlan, A., Coughlan, S., Bernard, S., & Santocanale, C. (2024) · FEBS Journal · doi:10.1111/febs.17127 · Cited by 5
Casso-Chapa, B., González, N. A. V., Le, N., Palaskas, N. L., Nead, K. T., Eutsey, L. P., Samanthapudi, V. S. K., Osborn, A. M., Lee, J., Mejia, G. F., et al. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.319870 · Cited by 5
Aging and tumors: a dynamic interaction
Zhang, Y., Zhu, S., Liu, Z., Hu, Y., Zhang, Y., Shang, L., & Li, L. (2025) · Discover Oncology · doi:10.1007/s12672-025-01808-9 · Cited by 5
JMJD3-mediated senescence is required to overcome stress-induced hematopoietic defects
Nakata, Y., Ueda, T., Sera, Y., Koizumi, M., Imamura, K., Kanai, A., Ikeda, K., Yamasaki, N., Nagamachi, A., Kobatake, K., et al. (2025) · EMBO Reports · doi:10.1038/s44319-025-00502-9 · Cited by 5
Zhang, W., Liu, L., Chen, R., Yan, H., Zhang, Q., Ren, X., Wang, H., Dong, Y., Xue, W., Zhai, Z., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-12108-1 · Cited by 6
Cellular senescence in colorectal cancer: its occurrence, effect and therapy
Liang, Y., Wang, M., Wang, X., Yang, Z., Wang, S., Li, F., Su, L., & Yang, L. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1580951 · Cited by 6
Yu, H., Ma, L., Zhang, X., Ren, Q., Yuan, Q., Zhou, J., Ren, Y., Wan, N., Jin, X., Hou, J., et al. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.115225 · Cited by 5
Zhou, W., Wang, L., Zhang, H., Wu, Y., Li, M., & Luo, Z. Y. (2025) · Theranostics · doi:10.7150/thno.119822 · Cited by 5
Isakova, A. A., Mazur, D. V., Антипова, Н. В., Николаевна, Д. И., Mozherov, A. M., Krasnov, K. S., Фадеев, Р. С., Kirpichnikov, M. P., Gasparian, M. E., & Yagolovich, A. V. (2025) · Medical Oncology · doi:10.1007/s12032-025-03130-4 · Cited by 5
Paulsohn, M.-B., Frahnert, K. H., Schlösser, D., Oschwald, J., Kopp, W., Fang, X., Schneider, C., Contreras, C. T., Danieli‐Mackay, A., Ludewig, F., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08362-w · Cited by 6
Shanker, P. R., & Dorajoo, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031613 · Cited by 5
Defining melanoma combination therapies that provide senolytic sensitivity in human melanoma cells
Tchelougou, D., Malaquin, N., Cardin, G. B., Desmul, J., Turcotte, S., & Rodier, F. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1368711 · Cited by 6
Directly Evolved Nanovaccines Modulate Disrupted Circadian Rhythm and Enhance Cancer Immunotherapy
Han, Z., Zhang, C., An, J., Wang, Y., Zeng, X., & Zhang, X. (2025) · Advanced Materials · doi:10.1002/adma.202502602 · Cited by 5
Iswarya, B. R., & John, C. M. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10904-6 · Cited by 5
Tran, T. T., & Lee, K. (2022) · Cancers · doi:10.3390/cancers14225714 · Cited by 6
Chen, R., Liu, M., Jiang, Q., Meng, X., & Wei, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1121603 · Cited by 6
Pádua, D., Figueira, P., Pinto, M., Maia, A. F., Peixoto, J., Lima, R. T., Pombinho, A. R., Pereira, C., Almeida, R., & Mesquita, P. (2023) · Cancers · doi:10.3390/cancers15174406 · Cited by 6
New Immunohistochemical Markers for Pleural Mesothelioma Subtyping
Stefano, I. D., Alì, G., Poma, A. M., Bruno, R., Proietti, A., Niccoli, C., Zirafa, C. C., Melfi, F. M. A., Mastromarino, M. G., Lucchi, M., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13182945 · Cited by 5
Prognostic Role of Mitochondrial Transcription Termination Factor 3 in Thyroid Carcinoma
Sun, M.-T., Zhao, H., Ruan, H.-J., Yu, L.-H., Guan, M.-L., Fan, J., Feng, C., & Lou, Y.-Y. (2023) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2023.0108 · Cited by 5
Regulation of cancer stem cells by CXCL1, a chemokine whose secretion is controlled by MCM2
Kahm, Y.-J., Kim, I., & Kim, R.-K. (2024) · BMC Cancer · doi:10.1186/s12885-024-12085-0 · Cited by 5
Transcription factor network dynamics during the commitment to oncogene-induced senescence
Vasilopoulos, T., & Martínez‐Zamudio, R. I. (2024) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2024.1423454 · Cited by 5
Proteomics Approaches to Define Senescence Heterogeneity and Chemotherapy Response
Petit, C., Guillon, J., Toutain, B., Boissard, A., Patsouris, A., Lelièvre, E., Guette, C., & Coqueret, O. (2019) · PROTEOMICS · doi:10.1002/pmic.201800447 · Cited by 5
Li, S., Cheng, Y., Chen, S., Qin, M., Li, P., & Yang, L. (2021) · Talanta · doi:10.1016/j.talanta.2021.122689 · Cited by 5
Multiple characteristic alterations and available therapeutic strategies of cellular senescence
Zhao, Y., Li, H., Guo, Q., & Hui, H. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200178 · Cited by 5
Therapeutic Potential of a Senolytic Approach in a Murine Model of Chronic GVHD
Raman, D., Chêne, C., Nicco, C., Jeljeli, M. M., Eu, J. Q., Clement, M., Batteux, F., & Pervaiz, S. (2023) · Biology · doi:10.3390/biology12050647 · Cited by 6
Improving consolidation therapy in acute myeloid leukemia - a tough nut to crack
Schlenk, R. F., Jaramillo, S., & Müller‐Tidow, C. (2018) · Haematologica · doi:10.3324/haematol.2018.200485 · Cited by 5
The Protective Role of DUSP4 in Retinal Pigment Epithelium Senescence and Degeneration
Liu, X., Ni, Z., Zhang, J., Lin, X., Wu, C., Wu, Y., Dong, L., Zhang, Z., & Chi, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083735 · Cited by 4
Ding, Y., Liu, Z., Liao, Y., Huang, K., Jiao, X., Zhu, J., Wang, H., Tao, Q., Guo, J., Xiong, S., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07306-4 · Cited by 4
Cellular senescence: A novel mechanism of therapeutic resistance in prostate cancer
Lin, C., Hadfield, M. J., Rathore, A., Pinho-Schwermann, M. P., Zhang, S., Lu, S., den Hollander, P., Mani, S. A., Seyhan, A. A., Santopietro, A., et al. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.103061 · Cited by 5
The Dual Effects of CDK4/6 Inhibitors on Tumor Immunity
Si, Y., Li, H., & Shi, Y. (2025) · Cancers · doi:10.3390/cancers17243997 · Cited by 5
Cortactin Suppresses mTOR-Dependent Senescence in Circulating Tumor Cells
Hu, J., Zhang, B., Chen, J., Huang, G., Zhao, M., Zhou, H., Yang, F., Liu, K., Zheng, S., Tan, H., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-1175 · Cited by 5
Sobeai, H. M. A., Alanazi, A. M., Alotaibi, F., Alhoshani, A., Alhazzani, K., Almutairi, M. M., Almudimeegh, S., al-Ramadi, B. K., Chakraborty, E., Saleh, T. M., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1661424 · Cited by 5
Zhang, Y., Liu, Y., Hu, X., Song, F., Zheng, S., Zheng, X., Sun, J., Li, L., & Huang, P. C. (2021) · Translational Andrology and Urology · doi:10.21037/tau-21-913 · Cited by 4
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research
Elshazly, A. M., Shahin, U., Shboul, S. A., Gewirtz, D. A., & Saleh, T. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000871 · Cited by 4
Endonucleosis mediates internalization of cytoplasm into the nucleus
Galanopoulou, O., Tachmatzidi, E. C., Deligianni, E., Botskaris, D., Nikolaou, K. C., Gargani, S., Dalezios, Y., Chalepakis, G., & Talianidis, I. (2024) · Nature Communications · doi:10.1038/s41467-024-50259-3 · Cited by 4
Kamada, K., Kurio, N., Mouri, Y., & Kudo, Y. (2024) · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · doi:10.1016/j.ajoms.2024.09.003 · Cited by 4
Koh, Y. W., Han, J.-H., Haam, S., & Lee, H. W. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111999 · Cited by 4
Haas, B., Roth, I., Säcker, L., Wos-Maganga, M., Beltzig, L., & Kaina, B. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03955-w · Cited by 4
Yan, H., Ding, Y., Dai, W., Wang, H., Qin, H., Zhai, Z., & Tao, Q. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01692-1 · Cited by 4
Metadata
- Authors
- Milanovic, M., Fan, D. N. Y., Belenki, D., Däbritz, J. H. M., Zhao, Z., Yu, Y., Dörr, J. R., Dimitrova, L., Lenze, D., Monteiro Barbosa, I. A., Mendoza-Parra, M. A., Kanashova, T., Metzner, M., Pardon, K., Reimann, M., Trumpp, A., Dörken, B., Zuber, J., Gronemeyer, H., Hummel, M., Dittmar, G., Lee, S., & Schmitt, C. A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- German Cancer Research Center (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Max Delbrück Center (DE)
- Centre National de la Recherche Scientifique (FR)
- Research Institute of Molecular Pathology (AT)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Corresponding author
- Schmitt, Clemens A.
- ORCID
- Venue
- Nature
- Published
- 2017-12-20
- Volume
- 553
- Issue
- 7686
- Pages
- 96-100
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2777786283
- Cited by
- 1,131
- References
- 60
- Citations by year
- 2026: 110 · 2025: 137 · 2024: 154 · 2023: 181 · 2022: 149 · 2021: 140 · 2020: 125 · 2019: 84 · 2018: 49 · 2017: 1
- FWCI
- 52.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, cancer stem cells, chemotherapy-induced senescence, senescence escape, Wnt signaling, H3K9me3, p53, p16INK4a, p21, B-cell lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, hematologic malignancies, clonogenic growth, self-renewal
- MeSH terms
- Animals, Clone Cells, Female, Humans, Male, Mice, Transgenic, Phenotype, Neoplastic Stem Cells, Biomarkers, Lymphoma, B-Cell, Cellular Senescence, Cell Line, Tumor, Cell Proliferation, Mice, Cell Cycle Checkpoints, Wnt Signaling Pathway, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.